Correlation Between Tonix Pharmaceuticals and Onconova Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and Onconova Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and Onconova Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and Onconova Therapeutics, you can compare the effects of market volatilities on Tonix Pharmaceuticals and Onconova Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of Onconova Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and Onconova Therapeutics.

Diversification Opportunities for Tonix Pharmaceuticals and Onconova Therapeutics

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Tonix and Onconova is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and Onconova Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Onconova Therapeutics and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with Onconova Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Onconova Therapeutics has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and Onconova Therapeutics go up and down completely randomly.

Pair Corralation between Tonix Pharmaceuticals and Onconova Therapeutics

Given the investment horizon of 90 days Tonix Pharmaceuticals Holding is expected to under-perform the Onconova Therapeutics. In addition to that, Tonix Pharmaceuticals is 1.05 times more volatile than Onconova Therapeutics. It trades about -0.11 of its total potential returns per unit of risk. Onconova Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest  76.00  in Onconova Therapeutics on August 29, 2024 and sell it today you would earn a total of  26.00  from holding Onconova Therapeutics or generate 34.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy31.45%
ValuesDaily Returns

Tonix Pharmaceuticals Holding  vs.  Onconova Therapeutics

 Performance 
       Timeline  
Tonix Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tonix Pharmaceuticals Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unfluctuating performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
Onconova Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Onconova Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Onconova Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Tonix Pharmaceuticals and Onconova Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tonix Pharmaceuticals and Onconova Therapeutics

The main advantage of trading using opposite Tonix Pharmaceuticals and Onconova Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, Onconova Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Onconova Therapeutics will offset losses from the drop in Onconova Therapeutics' long position.
The idea behind Tonix Pharmaceuticals Holding and Onconova Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bonds Directory
Find actively traded corporate debentures issued by US companies